GEODE CAPITAL MANAGEMENT, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 105 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$3,336,316
+6.6%
88,473
+7.2%
0.00%
Q2 2023$3,130,590
+133.3%
82,536
+439.5%
0.00%
Q4 2019$1,342,000
-3.5%
15,300
-17.0%
0.00%
Q3 2019$1,390,000
+3.7%
18,436
+17.5%
0.00%
Q2 2019$1,340,000
+11.7%
15,693
+41.3%
0.00%
Q1 2019$1,200,000
-2.1%
11,107
-23.5%
0.00%
Q4 2018$1,226,000
+285.5%
14,510
+348.3%
0.00%
Q3 2018$318,000
-2.8%
3,237
+14.0%
0.00%
Q2 2018$327,000
+33.5%
2,839
+13.9%
0.00%
Q1 2018$245,000
-52.1%
2,492
-49.1%
0.00%
Q4 2017$511,000
-87.2%
4,898
-86.3%
0.00%
-100.0%
Q3 2017$4,003,000
+1.7%
35,637
+1.1%
0.00%
-50.0%
Q2 2017$3,937,000
+8.8%
35,239
+13.4%
0.00%
+100.0%
Q1 2017$3,620,000
+19.6%
31,079
+8.0%
0.00%0.0%
Q4 2016$3,026,000
-6.7%
28,784
-2.1%
0.00%
-50.0%
Q3 2016$3,243,000
-14.5%
29,387
+12.5%
0.00%0.0%
Q2 2016$3,795,000
+92.2%
26,115
+89.0%
0.00%
+100.0%
Q1 2016$1,974,0000.0%13,817
+7.9%
0.00%0.0%
Q4 2015$1,974,000
+459.2%
12,809
+420.1%
0.00%
Q2 2015$353,000
-16.5%
2,463
-18.0%
0.00%
Q1 2015$423,000
-64.5%
3,004
-62.7%
0.00%
-100.0%
Q4 2014$1,193,000
+184.0%
8,054
+194.6%
0.00%
Q3 2014$420,0002,7340.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2019
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 582,409$90,011,00060.33%
GUARDIAN POINT CAPITAL, LP 70,000$10,819,00010.19%
Think Investments LP 186,373$28,804,0008.16%
Greywolf Capital Management LP 277,936$42,955,0007.45%
Valentine Capital Asset Management, Inc. 28,431$4,394,0004.91%
FORT, L.P. 63,675$9,841,0004.69%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 527,266$81,489,0003.63%
RPG Investment Advisory, LLC 60,910$9,413,0003.52%
Kerrisdale Advisers, LLC 81,996$12,672,0003.24%
Strategic Global Advisors, LLC 48,154$7,442,0003.17%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders